Category Archives: Newsroom

Strengthening Partnerships at Premier Integrated Lab’s Partner & Vendor Engagement Day

New corporate office sets the stage for collaboration, growth, and a shared vision for the future.

On 15 January 2025, Premier Integrated Labs (PIL) hosted its Partner & Vendor Engagement Day at the newly opened Corporate Office, bringing together partners and vendors in a refreshed and modern environment. This event provided a valuable opportunity to foster stronger collaborations, share insights, and discuss ways to achieve shared growth with our valued partners.

The day’s activities continued with the PIL Townhall 2025, where CEO En Hareeff took the stage to share significant company updates, celebrate recent achievements, and outline the vision for the year ahead. The townhall was an inspiring session that united the team, aligning everyone with the company’s goals and reinforcing PIL’s commitment to excellence and innovation.

This event was filled with meaningful connections and a renewed sense of purpose, setting the tone for a successful year ahead. PIL is excited to continue building on these strong partnerships and drive progress together.

Uniting for Women’s Health: Premier Integrated Labs and Roche Host Cervical Cancer Awareness Symposium

The Role of HPV Screening in Cervical Cancer Prevention

In collaboration with Roche, Premier Integrated Labs (PIL) hosted a successful symposium at The Vertical, Bangsar South, with over 50 attendees including GPs, hospitals, government agencies, and non-profit organizations on 8th December 2024. The event aimed to raise awareness of the critical issue of cervical cancer elimination and the importance of HPV primary screening in early detection and prevention. The symposium featured esteemed speakers such as Dr. Chew Ghee Kheng, Dr. Yogeeta A/P Gunasagran, and Dr. Khoo Su Pei, who shared their expertise on HPV screening and its significance in reducing cervical cancer mortality rates.

PIL is proud to support this effort, having processed over 60,000 HPV screening samples as part of government initiatives this year. We extend our gratitude to all participants for their dedication to improving patient care and contributing to the national effort to eliminate cervical cancer, building a future where women’s health is prioritized, and cervical cancer is no longer a threat.

MoU Signing with Taylor’s University and Appointment of Adjunct Lecturers

Premier Integrated Labs & Taylor’s University Bridging Academia and Industry for Biomedical Innovation

Premier Integrated Labs (PIL) and Taylor’s University officially established their collaboration through a Memorandum of Understanding (MoU) signing ceremony held at Taylor’s University on 28th November 2024. This strategic partnership represents a shared commitment to bridging the gap between academic learning and industry practices, creating transformative opportunities for students while driving advancements in biomedical research and diagnostics.

Starting next year, Taylor’s biomedical science students will have the opportunity to undergo practical training at PIL as part of their annual practicum placements. This hands-on experience will expose students to real-world diagnostic processes, equipping them with essential laboratory skills and industry knowledge that will enhance their professional development.

Beyond student training, the collaboration will foster research and innovation in clinical diagnostics and biomedical advancements. Both parties plan to engage in joint research projects and apply for competitive research funding to further explore and develop cutting-edge diagnostic solutions. By integrating academic expertise with industry-driven research, this partnership aims to contribute meaningful advancements to the healthcare sector.

Additionally, PIL’s experienced professionals will take on roles as adjunct lecturers at Taylor’s University, sharing valuable industry insights and practical perspectives with students. Their involvement will help bridge theoretical knowledge with real-world applications, ensuring that graduates are well-prepared to meet industry demands.

This collaboration marks the beginning of a promising partnership between PIL and Taylor’s University, laying the foundation for impactful educational experiences, groundbreaking research, and the continuous advancement of biomedical sciences.

Official Collaboration Between Premier Integrated Labs and Axon Alpha Specialist Centre

Premier Integrated Labs & Axon Alpha Specialist Centre Strengthening Diagnostic Excellence for Enhanced Patient Care

Premier Integrated Labs proudly celebrated its official collaboration with Axon Alpha Specialist Centre through the signing of a Memorandum of Understanding (MoU) at Pantai Hospital Kuala Lumpur on 23rd October 2024. This strategic partnership marks a significant step in strengthening diagnostic support and enhancing patient care.

By combining Premier Integrated Labs’ advanced laboratory expertise with Axon Alpha’s specialized medical services, we aim to provide seamless and efficient diagnostic solutions, ensuring timely and accurate results for better clinical decisions. This collaboration underscores our shared commitment to delivering high-quality healthcare, improving patient outcomes, and elevating the overall healthcare experience.

We look forward to a strong and fruitful partnership with Axon Alpha Specialist Centre, working together to bring innovative and reliable medical solutions to the communities we serve.

 

MoU between Premier Integrated Labs, Genomax Technologies, and Veracyte

Premier Integrated Labs, Genomax Technologies, and Veracyte collaborate to transform breast cancer care in Malaysia through a Memorandum of Understanding signing

The signing of the Memorandum of Understanding (MoU) between Premier Integrated Labs, Genomax Technologies, and Veracyte marks a significant milestone in advancing breast cancer care in Malaysia. The MoU was signed by Mr. Sayyidi Hamzi, Senior Manager of Premier Integrated Labs, Mr. Wong Lin Sheng, Managing Director of Genomax Technologies and Dr. Bertrand Farnault, Commercial Director of IVD at Veracyte. This collaboration introduces the Prosigna® Breast Cancer Assay (PAM50), making Premier Integrated Labs the sole local service provider of this cutting-edge diagnostic tool in Southeast Asia. We are driven by the belief that early, precise diagnosis is essential to improving patient outcomes.

Through this partnership, we are equipping healthcare providers with the latest genomic insights, empowering them to offer personalized treatment strategies to breast cancer patients. Together, we are transforming breast cancer care and helping patients make informed decisions about their treatment options.